{"id":541,"date":"2022-09-08T18:14:20","date_gmt":"2022-09-08T18:14:20","guid":{"rendered":"https:\/\/medicalmarijuanainc.com\/?p=1013735"},"modified":"2022-09-08T18:14:20","modified_gmt":"2022-09-08T18:14:20","slug":"medical-marijuana-inc-signs-deal-with-leading-european-manufacturer-and-distributor-to-expand-channel-access-to-products-throughout-the-region","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2022\/09\/08\/medical-marijuana-inc-signs-deal-with-leading-european-manufacturer-and-distributor-to-expand-channel-access-to-products-throughout-the-region\/","title":{"rendered":"Medical Marijuana, Inc. Signs Deal With Leading European Manufacturer and Distributor to Expand Channel Access to Products Throughout the Region"},"content":{"rendered":"
Global Cannabis Company Expands Supply Chain in Europe through Agreement with Complete Hemp Technologies<\/i><\/p>\n
SAN DIEGO, CA, Sept. 08, 2022 (GLOBE NEWSWIRE) — via\u00a0NewMediaWire<\/a>\u00a0\u2013\u00a0Medical Marijuana, Inc.<\/a>\u00a0(OTC: MJNA) (the \u201cCompany\u201d), the first-ever publicly traded cannabis company in the United States that launched the world\u2019s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary, Kannaway, has signed a distribution agreement with long-time partner Complete Hemp Technologies (CHT) to expand its capabilities in the European market. The agreement adds warehousing and daily operations to the services that CHT already provides to Kannaway in Europe, providing cost-savings and gross margins improvements in one of the Company\u2019s largest international markets.<\/p>\n The Company has worked with CHT for years to facilitate expansion throughout Europe, leveraging their strong relationships with regulators and industry leading cannabis based product capabilities.\u00a0 CHT will also now provide distribution services eliminating the need to transport product after manufacture as well as fund additional warehouse space and associated labor costs.<\/p>\n \u201cAs the first US company to enter Europe with our hemp-based products, we have built long-standing relationships with the region\u2019s most knowledgeable companies and this agreement is a perfect example of that,\u201d said Medical Marijuana, Inc. CEO Blake Schroeder. \u201cIt is a win-win for both companies. We will continue to leverage our superior product formulations and brand equity as the original trusted source for quality products, while being supported by a reputable company with a proven track record of success.\u201d<\/p>\n \u201cWe are happy to continue to work with Medical Marijuana, Inc. and its family of companies,\u201d said Rafal Modlinski, CEO of Complete Hemp Technologies. \u201cTheir dedication to creating quality products and distributing them on a global basis fully aligns with our vision here at CHT. Through this agreement we will be able to expand both our reach and the reach of Medical Marijuana, Inc. and Kannaway products.\u201d<\/p>\n ABOUT MEDICAL MARIJUANA, INC.:<\/b><\/p>\n We are a company of firsts\u00ae<\/a>. Medical Marijuana, Inc. (MJNA<\/a>) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by\u00a0Kannaway\u00ae<\/a>\u00a0and\u00a0HempMeds\u00ae<\/a>; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including\u00a0AXIM\u00ae Biotechnologies, Inc<\/a>.<\/a>\u00a0and\u00a0Neuropathix<\/a>. Medical Marijuana, Inc. was named a top CBD producer by\u00a0CNBC<\/a>. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product\u00a0Real Scientific Hemp Oil<\/a>\u00a0has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.<\/p>\n Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at\u00a0OTCMarkets.com<\/a>\u00a0or by visiting\u00a0www.medicalmarijuanainc.com<\/a>. To see Medical Marijuana, Inc.’s corporate video,\u00a0click here<\/a>.<\/p>\n FORWARD-LOOKING DISCLAIMER:<\/b><\/p>\n This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and\/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.<\/p>\n FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE:<\/b><\/p>\n These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.<\/p>\n LEGAL DISCLOSURE:<\/b><\/p>\n Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.<\/p>\n CONTACT:<\/b><\/p>\n Public Relations Contact:<\/b> Investor Relations Contact:<\/b> Global Cannabis Company Expands Supply Chain in Europe through Agreement with Complete Hemp Technologies SAN DIEGO, CA, Sept. 08, 2022 (GLOBE NEWSWIRE) — via\u00a0NewMediaWire\u00a0\u2013\u00a0Medical Marijuana, Inc.\u00a0(OTC: MJNA) (the \u201cCompany\u201d), the first-ever publicly traded cannabis company in the United States that launched the world\u2019s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its […]<\/p>\n","protected":false},"author":1,"featured_media":542,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":" Global Cannabis Company Expands Supply Chain in Europe through Agreement with Complete Hemp Technologies<\/i><\/p>\r\nSAN DIEGO, CA, Sept. 08, 2022 (GLOBE NEWSWIRE) -- via\u00a0NewMediaWire<\/a>\u00a0\u2013\u00a0Medical Marijuana, Inc.<\/a>\u00a0(OTC: MJNA) (the \u201cCompany\u201d), the first-ever publicly traded cannabis company in the United States that launched the world\u2019s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary, Kannaway, has signed a distribution agreement with long-time partner Complete Hemp Technologies (CHT) to expand its capabilities in the European market. The agreement adds warehousing and daily operations to the services that CHT already provides to Kannaway in Europe, providing cost-savings and gross margins improvements in one of the Company\u2019s largest international markets.\r\n\r\nThe Company has worked with CHT for years to facilitate expansion throughout Europe, leveraging their strong relationships with regulators and industry leading cannabis based product capabilities.\u00a0 CHT will also now provide distribution services eliminating the need to transport product after manufacture as well as fund additional warehouse space and associated labor costs.\r\n\r\n\u201cAs the first US company to enter Europe with our hemp-based products, we have built long-standing relationships with the region\u2019s most knowledgeable companies and this agreement is a perfect example of that,\u201d said Medical Marijuana, Inc. CEO Blake Schroeder. \u201cIt is a win-win for both companies. We will continue to leverage our superior product formulations and brand equity as the original trusted source for quality products, while being supported by a reputable company with a proven track record of success.\u201d\r\n\r\n\u201cWe are happy to continue to work with Medical Marijuana, Inc. and its family of companies,\u201d said Rafal Modlinski, CEO of Complete Hemp Technologies. \u201cTheir dedication to creating quality products and distributing them on a global basis fully aligns with our vision here at CHT. Through this agreement we will be able to expand both our reach and the reach of Medical Marijuana, Inc. and Kannaway products.\u201d\r\n\r\nABOUT MEDICAL MARIJUANA, INC.:<\/b>\r\n\r\nWe are a company of firsts\u00ae<\/a>. Medical Marijuana, Inc. (MJNA<\/a>) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by\u00a0Kannaway\u00ae<\/a>\u00a0and\u00a0HempMeds\u00ae<\/a>; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including\u00a0AXIM\u00ae Biotechnologies, Inc<\/a>.<\/a>\u00a0and\u00a0Neuropathix<\/a>. Medical Marijuana, Inc. was named a top CBD producer by\u00a0CNBC<\/a>. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company's flagship product\u00a0Real Scientific Hemp Oil<\/a>\u00a0has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.\r\n\r\nMedical Marijuana, Inc.'s headquarters is in San Diego, California, and additional information is available at\u00a0OTCMarkets.com<\/a>\u00a0or by visiting\u00a0www.medicalmarijuanainc.com<\/a>. To see Medical Marijuana, Inc.'s corporate video,\u00a0click here<\/a>.\r\n\r\nFORWARD-LOOKING DISCLAIMER:<\/b>\r\n\r\nThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and\/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.\r\n\r\nFOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE:<\/b>\r\n\r\nThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.\r\n\r\nLEGAL DISCLOSURE:<\/b>\r\n\r\nMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.\r\n\r\nCONTACT:<\/b>\r\n\r\nPublic Relations Contact:<\/b>\r\nKyle Porter\r\nCEO\r\nCMW Media\r\nP. 858-221-8001\r\nmjna@cmwmedia.com<\/a>\r\nwww.cmwmedia.com<\/a>\r\n\r\nInvestor Relations Contact:<\/b>\r\nP. (858) 283-4016\r\nInvestors@medicalmarijuanainc.com","_et_gb_content_width":"","footnotes":""},"categories":[3,2],"tags":[],"class_list":["post-541","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news","category-press-releases"],"yoast_head":"\n
\nKyle Porter
\nCEO
\nCMW Media
\nP. 858-221-8001
\nmjna@cmwmedia.com<\/a>
\nwww.cmwmedia.com<\/a><\/p>\n
\nP. (858) 283-4016
\nInvestors@medicalmarijuanainc.com<\/p>\n","protected":false},"excerpt":{"rendered":"